Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Buy on Insulet, Lowers Price Target to $310

Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $350 to $310.

byBenzinga Newsdesk

May 17, 2022

1 minute read

Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $350 to $310.

Morgan Stanley Maintains Underweight on Bright Horizons Family, Lowers Price Target to $111

By Benzinga Newsdesk

Today, 8:09 AM

Morgan Stanley maintains Bright Horizons Family (NYSE:BFAM) with a Underweight and lowers the price target from $130 to $111.

BFAM

Alibaba Down Over 2%, Nio Jumps 7%: What’s Weighing On Hong Kong Stocks Today?

By Navdeep Yadav

Today, 8:09 AM

Shares of U.S.-listed Chinese firms traded mixed in Hong Kong on Wednesday morning, with web search giant Baidu Inc (NASDAQ: BIDU) and electric vehicle maker NIO Inc (NYSE: NIO) among stocks that were in the green.

BABA

Analyst Ratings

Expert Ratings For Anthem

By Benzinga Insights

Today, 8:09 AM

Anthem (NYSE:ANTM) has observed the following analyst ratings within the last quarter:

ANTM

Goldman Sachs Maintains Buy on Equinix, Raises Price Target to $920

By Benzinga Newsdesk

Today, 8:09 AM

Goldman Sachs analyst Brett Feldman maintains Equinix (NASDAQ:EQIX) with a Buy and raises the price target from $830 to $920.

EQIX

Citigroup Maintains Buy on Insulet, Lowers Price Target to $310

Related Posts

Morgan Stanley Maintains Underweight on Bright Horizons Family, Lowers Price Target to $111

Alibaba Down Over 2%, Nio Jumps 7%: What’s Weighing On Hong Kong Stocks Today?

Expert Ratings For Anthem

Goldman Sachs Maintains Buy on Equinix, Raises Price Target to $920